Literature DB >> 7464090

An efficient technique for determining characteristics of saccadic eye movements using a mini computer.

A T Smith, P R Bittencourt, D S Lloyd, A Richens.   

Abstract

A new technique has been developed to quantify objectively certain characteristics of saccadic eye movements which can be used as indices of the effect of centrally-acting compounds. During a three minute test session subjects sit with their heads in a fixed position and are asked to follow horizontal step displacements of a spot on a CRT screen, driven by signals previously recorded on FM analogue tape. Displacements of the spot are produced at random intervals which result in saccadic eye movements having amplitudes 10 degrees to 40 degrees. The corneo-retinal potentials are d.c. amplified and stored on the same on the same tape, later sampled at 256 Hz, filtered, differentiated and compared to the spot-displacement signal. Reaction time, duration, peak velocity, post saccadic interval and saccadic accuracy are then determined. Efficient use of computer resources has been achieved with improvements in control of experimental conditions, in reliability and in accuracy of measurements. Automatic unbiased rejection of erroneous data has been achieved. The efficiency of the technique has made extensive clinical trials possible in an environment where computer power is not devoted to eye movement-measurements. In confirmation of previous work the peak velocity characteristic has been identified as a sensitive measure of the effect of several benzodiazepines.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7464090     DOI: 10.1016/0141-5425(81)90103-5

Source DB:  PubMed          Journal:  J Biomed Eng        ISSN: 0141-5425


  14 in total

1.  A microcomputer system for clinical signal analysis of vestibular laboratory.

Authors:  M Juhola; I Pyykkö; H Aalto
Journal:  J Med Syst       Date:  1989-08       Impact factor: 4.460

2.  Computerised eye-movement processor for clinical applications: basic considerations and design.

Authors:  J P Reulen; R van Heuningen; G Tiesinga; J E Bos
Journal:  Med Biol Eng Comput       Date:  1986-03       Impact factor: 2.602

3.  Saccadic eye movement analysis as a measure of drug effects on human psychomotor performance.

Authors:  A N Griffiths; R W Marshall; A Richens
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

4.  Saccadic eye movements analysis as a measure of drug effect on central nervous system function.

Authors:  G Tedeschi; A Quattrone; V Bonavita
Journal:  Ital J Neurol Sci       Date:  1986-04

5.  The relationship between peak velocity of saccadic eye movements and serum benzodiazepine concentration.

Authors:  P R Bittencourt; P Wade; A T Smith; A Richens
Journal:  Br J Clin Pharmacol       Date:  1981-10       Impact factor: 4.335

6.  Rate of entrance of benzodiazepines into the brain determined by eye movement recording.

Authors:  G Tedeschi; A T Smith; S Dhillon; A Richens
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335

7.  The effect of repeated doses of temazepam and nitrazepam on human psychomotor performance.

Authors:  G Tedeschi; A N Griffiths; A T Smith; A Richens
Journal:  Br J Clin Pharmacol       Date:  1985-10       Impact factor: 4.335

8.  The effects of acrivastine (BW825C), diphenhydramine and terfenadine in combination with alcohol on human CNS performance.

Authors:  A F Cohen; M J Hamilton; A W Peck
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

9.  The effects of the "vestibular sedative" drug, Flunarizine upon the vestibular and oculomotor systems.

Authors:  J Ell; M Gresty
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-08       Impact factor: 10.154

10.  Lamotrigine (BW430C), a potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepam.

Authors:  A F Cohen; L Ashby; D Crowley; G Land; A W Peck; A A Miller
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.